Factor This Power Engineering
Live Events
DTECH® Events
POWERGENâ¢
Calendar
Webinars
Podcasts
Contribute Content
Solar
Community
Residential
Utility Scale
Wind Power
Offshore
Turbines & Equipment
Power Grid
Distribution
Grid Modernization
Microgrids
Outage Management
Smart Grids
Transmission
Hydropower
Dams & Civil Structures
Small Hydropower
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Long Duration
Pumped Storage
Business
Finance
Policy & Regulation
Project Development
Tariffs
Electric Vehicles
EV Charging
Vehicle to Grid
Subscribe
Solar
Community
Residential
Utility Scale
Wind Power
Offshore
Turbines & Equipment
Power Grid
Distribution
Grid Modernization
Microgrids
Outage Management
Transmission
Smart Grids
Hydropower
Dams & Civil Structures
Small Hydro
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Long Duration
Pumped Storage
Business
Finance
Policy & Regulation
Electric Vehicles
EV Charging
Vehicle to Grid
Factor This: Power Engineering
Live Events
DISTRIBUTECH®
Podcasts
Webinars
Calendar
Contribute Content
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Hydroworld Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Immunome, Inc.
< Previous
1
2
3
4
Next >
Immunome Announces Oral Presentation of Phase 3 RINGSIDE Data at 2026 ASCO Annual Meeting
April 21, 2026
From
Immunome, Inc.
Via
Business Wire
Tickers
IMNM
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 02, 2026
From
Immunome, Inc.
Via
Business Wire
Tickers
IMNM
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 05, 2026
From
Immunome, Inc.
Via
Business Wire
Tickers
IMNM
Immunome Reports Full Year 2025 Financial Results and Provides Business Update
March 03, 2026
From
Immunome, Inc.
Via
Business Wire
Tickers
IMNM
Immunome to Present at Upcoming Investor Conferences
February 23, 2026
From
Immunome, Inc.
Via
Business Wire
Tickers
IMNM
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 05, 2026
From
Immunome, Inc.
Via
Business Wire
Tickers
IMNM
Immunome to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026
February 04, 2026
From
Immunome, Inc.
Via
Business Wire
Tickers
IMNM
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 08, 2026
From
Immunome, Inc.
Via
Business Wire
Tickers
IMNM
Immunome to Present at 44th Annual J.P. Morgan Healthcare Conference
January 06, 2026
From
Immunome, Inc.
Via
Business Wire
Tickers
IMNM
Immunome Announces Pricing of Public Offering of Common Stock
December 16, 2025
From
Immunome, Inc.
Via
Business Wire
Tickers
IMNM
Immunome Announces Proposed Public Offering of Common Stock
December 15, 2025
From
Immunome, Inc.
Via
Business Wire
Tickers
IMNM
Immunome Announces Positive Topline Results from Phase 3 RINGSIDE Trial of Varegacestat in Patients with Desmoid Tumors
December 15, 2025
From
Immunome, Inc.
Via
Business Wire
Tickers
IMNM
Immunome to Announce Topline Results from Phase 3 RINGSIDE Trial of Varegacestat in Patients with Desmoid Tumors
December 14, 2025
From
Immunome, Inc.
Via
Business Wire
Tickers
IMNM
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 04, 2025
From
Immunome, Inc.
Via
Business Wire
Tickers
IMNM
Immunome to Present at Upcoming Investor Conferences
November 25, 2025
From
Immunome, Inc.
Via
Business Wire
Tickers
IMNM
Immunome Reports Third Quarter 2025 Financial Results and Provides Business Update
November 06, 2025
From
Immunome, Inc.
Via
Business Wire
Tickers
IMNM
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 04, 2025
From
Immunome, Inc.
Via
Business Wire
Tickers
IMNM
Immunome to Present at 2nd Annual Guggenheim Healthcare Innovation Conference
October 31, 2025
From
Immunome, Inc.
Via
Business Wire
Tickers
IMNM
Immunome Presents Preclinical Data Showing Proprietary TOP1i ADC Payload HC74 Overcomes Multiple Mechanisms of ADC Resistance
October 23, 2025
From
Immunome, Inc.
Via
Business Wire
Tickers
IMNM
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 02, 2025
From
Immunome, Inc.
Via
Business Wire
Tickers
IMNM
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 04, 2025
From
Immunome, Inc.
Via
Business Wire
Tickers
IMNM
Immunome to Present at the H.C. Wainwright 27th Annual Global Investment Conference
September 03, 2025
From
Immunome, Inc.
Via
Business Wire
Tickers
IMNM
Immunome Reports Second Quarter 2025 Financial Results and Provides Business Update
August 06, 2025
From
Immunome, Inc.
Via
Business Wire
Tickers
IMNM
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 01, 2025
From
Immunome, Inc.
Via
Business Wire
Tickers
IMNM
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 03, 2025
From
Immunome, Inc.
Via
Business Wire
Tickers
IMNM
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 05, 2025
From
Immunome, Inc.
Via
Business Wire
Tickers
IMNM
Immunome to Present at Upcoming Investor Conferences
May 22, 2025
From
Immunome, Inc.
Via
Business Wire
Tickers
IMNM
Immunome Reports First Quarter 2025 Financial Results and Provides Business Update
May 12, 2025
From
Immunome, Inc.
Via
Business Wire
Tickers
IMNM
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 02, 2025
From
Immunome, Inc.
Via
Business Wire
Tickers
IMNM
Immunome to Present at the 24th Annual Needham Virtual Healthcare Conference
April 04, 2025
From
Immunome, Inc.
Via
Business Wire
Tickers
IMNM
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
